top of page

Animal Cancer: A $Billion Industry, Growing Concern and Innovative Solutions

Harvest Communications

Sep 16, 2024

From a Graduate Thesis to Revolutionary Pet Cancer Treatments

Cancer in pets has become an increasingly prevalent issue, affecting millions of companion animals worldwide.

According to recent studies,

approximately 50% of dogs over the age of 10 will develop cancer, making it a leading cause of death in older pets.

This sobering statistic has led to a surge in research and development of innovative treatments in veterinary oncology.



Challenges and Limitations

One of the primary challenges in treating animal cancer is the limited availability of specialized care. With only about 400 veterinary oncologists practicing nationwide in the United States, access to expert treatment can be difficult for many pet owners. Additionally, the high cost of traditional cancer therapies, such as chemotherapy and radiation, can be prohibitive for many families.


Despite these challenges, there have been significant advancements in animal cancer treatments. From targeted therapies to immunotherapies, the field of veterinary oncology has made great strides in recent years.


Early signs of Pet Cancer...

Progress and Success

Success rates vary depending on the type and stage of cancer, but early detection and treatment have shown to significantly improve outcomes for many pets.


At the forefront of this innovation is Torigen Pharmaceuticals, a company founded by Ashley Kalinauskas. Torigen has developed a groundbreaking approach to treating cancer in pets using personalized immunotherapy.


Interviewed on The Harvest Podcast recently, Carmel Fisher discovered inspiring insights from Ashley, into this growing industry.


Watch the full episode here:




Their autologous cancer vaccine utilizes the pet's own tumor cells to create a tailored treatment that stimulates the immune system to fight against the cancer.



Torigen = Accessibility and Affordability

What sets Torigen's approach apart is its accessibility and affordability. Unlike traditional treatments that often require specialized facilities, Torigen's therapy can be administered by any veterinarian, greatly expanding access to cancer care for pets. The company has reported promising results, particularly in treating aggressive cancers like hemangiosarcoma, where they've seen survival rates increase by up to three and a half times compared to standard care.


Moreover, Torigen's success extends beyond oncology. The company is exploring applications of their technology in other areas of pet health, including atopic dermatitis, a billion-dollar market in veterinary care.

As the field of animal cancer treatment continues to evolve, companies like Torigen are paving the way for more effective, accessible, and affordable options for pet owners.


With ongoing research and development, the future looks brighter for our furry companions facing cancer diagnoses, offering hope to millions of pets and their families worldwide.




Sources:

The Harvest Podcast

Torigen Pharmaceuticals

Early Signs of Pet Cancer

© 2024 Harvest Communications. All rights reserved.

bottom of page